Meet our team at the 13th International Conference on Biologics and Biosimilars

Our bioanalytical experts will be available to meet with you at the 13th International Conference on Biologic and Biosimilars in Boston, MA, USA on October 24-25, 2018.

Intertek specializes in biosimilar quality and safety testing, and is a world leading provider of immunochemistry and biomarker services for bioanalytical studies supporting the preclinical and clinical development of protein based therapeutics and other biologic medicines.

REQUEST A MEETING

The theme for this year’s conference is “Emerging Trends in Biosimilars Development and Approval”. The conference will focus on 18 session tracks, including Current Challenges in Developing Biosimilars; Biopharmaceuticals; Emerging Biosimilars in Therapeutics; and Regulatory Approach for Biosimilars.